Pharmaceutical Preparations · DE · CIK 1607678
Develops drug candidates for unmet medical needs through clinical trials
Comparable business profile · signals at a glance
In the 90 days to Mar 10, 2026: 1 insider bought $150K · 4 sold $12.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 | Aubuchon Neil WilliamChief Commercial Officer | Buy | 4,475 | $33.50 | $150K |
| Jan 5, 2026 | Lian BrianPresident & CEO | Sell | 132,454 | $32.29 | $4.3M |
| Jan 5, 2026 | Lian BrianPresident & CEO | Sell | 53,279 | $33.38 | $1.8M |
| Jan 5, 2026 | Lian BrianPresident & CEO | Sell | 41,276 | $34.22 | $1.4M |
| Jan 5, 2026 | Zante GregChief Financial Officer | Sell | 31,961 | $32.30 | $1.0M |
| Jan 5, 2026 | Mancini MariannaChief Operating Officer | Sell | 31,961 | $32.29 | $1.0M |
| Jan 5, 2026 | Zante GregChief Financial Officer | Sell | 13,900 | $33.38 | $464K |
| Jan 5, 2026 | Mancini MariannaChief Operating Officer | Sell | 13,600 | $33.37 | $454K |
| Jan 5, 2026 | Mancini MariannaChief Operating Officer | Sell | 10,500 | $34.22 | $359K |
| Jan 5, 2026 | Zante GregChief Financial Officer | Sell | 10,300 | $34.24 | $353K |
| Jan 5, 2026 | Lian BrianPresident & CEO | Sell | 6,400 | $35.07 | $224K |
| Jan 5, 2026 | Mancini MariannaChief Operating Officer | Sell | 1,600 | $35.07 | $56K |
| Jan 5, 2026 | Zante GregChief Financial Officer | Sell | 1,500 | $32.09 | $48K |
| Jan 2, 2026 | Foehr Matthew WDirector | Sell | 16,000 | $35.11 | $562K |
| Oct 28, 2025 | Lian BrianPresident & CEO | Sell | 38,989 | $35.01 | $1.4M |
| Oct 28, 2025 | Mancini MariannaChief Operating Officer | Sell | 6,185 | $35.00 | $216K |
| Oct 28, 2025 | Zante GregChief Financial Officer | Sell | 6,185 | $35.00 | $216K |
| Oct 27, 2025 | Rowland Charles A JrDirector | Sell | 60,000 | $35.57 | $2.1M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗